BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3876493)

  • 21. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).
    Ledbetter JA; Shu G; Gallagher M; Clark EA
    J Immunol; 1987 Feb; 138(3):788-94. PubMed ID: 3492534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinction of B cell maturation factors from lymphokines affecting B cell growth and viability.
    Sherris DI; Sidman CL
    J Immunol; 1986 Feb; 136(3):994-8. PubMed ID: 3079808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.
    Muraguchi A; Kehrl JH; Butler JL; Fauci AS
    J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro analysis of allogeneic lymphocyte interaction. VIII. Characterization of helper components of allogeneic effect factor (AEF) that activate Lyb5+ and Lyb5- B cells to respond to thymus-dependent and thymus-independent antigens.
    Delovitch TL; Kaufman K; Gorczynski RD; Sinclair GD
    J Immunol; 1983 Nov; 131(5):2246-53. PubMed ID: 6605380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B cell maturation factor: effects on various cell populations.
    Sidman CL; Marshall JD
    J Immunol; 1984 Feb; 132(2):845-50. PubMed ID: 6418813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferation of human malignant lymphocytes induced by anti-IgM independent of B cell growth factor.
    Baeker TR; Rothstein TL
    J Immunol; 1985 May; 134(5):3532-8. PubMed ID: 3872333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased phosphatidylinositol metabolism is an important but not an obligatory early event in B lymphocyte activation.
    Grupp SA; Harmony JA
    J Immunol; 1985 Jun; 134(6):4087-94. PubMed ID: 2580904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of cation transport by lymphokines in B cells without induction of DNA synthesis or immunoglobulin gene transcription.
    Fotedar R; Severini A; Holowachuk EW; Shiozawa CS; Paetkau V; Kaplan JG; Diener E
    J Immunol; 1986 Jan; 136(2):562-8. PubMed ID: 3001179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphokines regulate immunoglobulin isotype expression in an antigen-specific immune response.
    Tesch H; Müller W; Rajewsky K
    J Immunol; 1986 Apr; 136(8):2892-5. PubMed ID: 2420875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constitutive production by the WEHI-3 cell line of B cell growth and differentiation factor that co-purifies with interleukin 1.
    Booth RJ; Prestidge RL; Watson JD
    J Immunol; 1983 Sep; 131(3):1289-93. PubMed ID: 6604093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphoma models for B cell activation and tolerance. I. Conditions for the anti-mu-dependent stimulation of growth in NBL, a nude B cell lymphoma.
    Ling M; Livnat D; Pillai PS; Scott DW
    J Immunol; 1985 Mar; 134(3):1449-54. PubMed ID: 2578509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signals in B lymphocyte proliferation and differentiation.
    Schimpl A
    Ann Immunol (Paris); 1983; 134D(1):143-53. PubMed ID: 6354067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells.
    Coffman RL; Ohara J; Bond MW; Carty J; Zlotnik A; Paul WE
    J Immunol; 1986 Jun; 136(12):4538-41. PubMed ID: 3486902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
    Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML
    J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro.
    Snapper CM; Waegell W; Beernink H; Dasch JR
    J Immunol; 1993 Nov; 151(9):4625-36. PubMed ID: 8409423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of BCGFII in the differentiation to antibody secretion normal and tumor B cells.
    Swain SL
    J Immunol; 1985 Jun; 134(6):3934-43. PubMed ID: 2580899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation and proliferation signals in mouse B cells. I. A comparison of the capacity of anti-Ig antibodies or phorbol myristic acetate to activate B cells from CBA/N or normal mice into G1.
    Hawrylowicz CM; Keeler KD; Klaus GG
    Eur J Immunol; 1984 Mar; 14(3):244-50. PubMed ID: 6200334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The requirement for high intracellular cyclic adenosine monophosphate concentrations distinguishes two pathways of B cell activation induced with lymphokines and antibody to immunoglobulin.
    Hoffmann MK
    J Immunol; 1988 Jan; 140(2):580-2. PubMed ID: 2826594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of T cell-derived lymphokines containing B cell differentiation factor(s) for IgG (BCDF gamma) on gamma-specific mRNA in murine B cells.
    Jones S; Chen YW; Isakson P; Layton J; Pure E; Word C; Krammer PH; Tucker P; Vitetta ES
    J Immunol; 1983 Dec; 131(6):3049-51. PubMed ID: 6605997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of cell morphology in B lymphocytes by IL-4: evidence for induced cytoskeletal changes.
    Davey EJ; Thyberg J; Conrad DH; Severinson E
    J Immunol; 1998 Jun; 160(11):5366-73. PubMed ID: 9605136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.